Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,050 | 234 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $954.50 | 44 | $0 (2024) |
| Novo Nordisk Inc | $915.75 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $625.20 | 23 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $482.92 | 5 | $0 (2024) |
| Amgen Inc. | $405.40 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $341.64 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $286.52 | 6 | $0 (2024) |
| Abbott Laboratories | $283.64 | 2 | $0 (2024) |
| Lilly USA, LLC | $245.43 | 10 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $230.88 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,621 | 52 | Abbott Laboratories ($283.64) |
| 2023 | $1,368 | 49 | Novo Nordisk Inc ($279.87) |
| 2022 | $1,439 | 53 | Novo Nordisk Inc ($364.09) |
| 2021 | $1,040 | 54 | AstraZeneca Pharmaceuticals LP ($267.62) |
| 2020 | $457.80 | 25 | Amarin Pharma Inc. ($154.59) |
| 2019 | $125.00 | 1 | GlaxoSmithKline, LLC. ($125.00) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 11/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 07/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $144.99 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DIABETES | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 657 | 1,345 | $170,610 | $81,120 |
| 2022 | 24 | 708 | 1,447 | $183,590 | $90,725 |
| 2021 | 16 | 427 | 772 | $88,280 | $51,830 |
| 2020 | 10 | 316 | 524 | $63,820 | $30,713 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 205 | $39,020 | $20,539 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 169 | $25,350 | $12,150 | 47.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 165 | $13,200 | $7,054 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $11,250 | $6,346 | 56.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 111 | $11,100 | $6,093 | 54.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 91 | $10,920 | $4,130 | 37.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 44 | 44 | $6,600 | $3,656 | 55.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 45 | $4,725 | $3,362 | 71.1% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 27 | 27 | $4,860 | $2,727 | 56.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 28 | 29 | $5,075 | $2,020 | 39.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 48 | $3,600 | $2,006 | 55.7% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 18 | 18 | $13,500 | $1,876 | 13.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $2,070 | $1,654 | 79.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 18 | 18 | $2,710 | $1,430 | 52.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 14 | 30 | $1,800 | $1,044 | 58.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 21 | 22 | $2,420 | $1,006 | 41.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,080 | $917.19 | 84.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 21 | 22 | $1,980 | $865.80 | 43.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 27 | 27 | $1,620 | $864.27 | 53.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 22 | $2,420 | $518.20 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 38 | $3,230 | $450.62 | 14.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 29 | 89 | $1,780 | $282.48 | 15.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 29 | 30 | $300.00 | $127.31 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 213 | $33,015 | $22,008 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 151 | $22,625 | $11,515 | 50.9% |
About Dr. Mamatha Mohan, M.D
Dr. Mamatha Mohan, M.D is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710016761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mamatha Mohan, M.D has received a total of $6,050 in payments from pharmaceutical and medical device companies, with $1,621 received in 2024. These payments were reported across 234 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,050).
As a Medicare-enrolled provider, Mohan has provided services to 2,108 Medicare beneficiaries, totaling 4,088 services with total Medicare billing of $254,388. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location East Orange, NJ
- Active Since 03/05/2007
- Last Updated 07/27/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1710016761
Products in Payments
- JARDIANCE (Drug) $526.20
- Kerendia (Drug) $482.92
- Ozempic (Drug) $467.97
- FARXIGA (Drug) $370.50
- Repatha (Biological) $330.54
- FASENRA (Biological) $315.14
- VERQUVO (Drug) $270.99
- BREZTRI (Drug) $237.59
- QUVIVIQ (Drug) $230.88
- Vascepa (Drug) $211.61
- Rybelsus (Drug) $197.78
- TRELEGY ELLIPTA (Drug) $180.68
- Barostim Neo System (Device) $174.89
- MOUNJARO (Drug) $159.50
- FREESTYLE LIBRE 3 (Device) $144.99
- MITRACLIP (Device) $138.65
- AREXVY (Drug) $105.84
- LEQVIO (Drug) $100.77
- ENTRESTO (Drug) $99.15
- LifeVest (Device) $79.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Orange
Dr. Alexander Salerno, Md, MD
Internal Medicine — Payments: $73,770
Dr. Gitendra Rajiyah, Md, MD
Internal Medicine — Payments: $20,111
Eddy Simon, Md, MD
Internal Medicine — Payments: $7,943
Dr. Anand Srinivasan, Md, MD
Internal Medicine — Payments: $7,905
Dr. Radhika Maddali, Md, MD
Internal Medicine — Payments: $6,737
Robert Clarke, Md, MD
Internal Medicine — Payments: $5,522